Physician profile
Michael G Isaac
NPI 1558398222
$66,949.53
in general payments reported to CMS, 2019-2025
46 companies · $634 in 2025
The $634 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $11K · 2021: $4,071 · 2022: $5,681 · 2023: $1,280 · 2024: $1,180 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,093.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $52,615.20 | 2019-2020 | |
| Medtronic, INC. | $8,107.51 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $559.03 | 2019-2024 | |
| Amgen INC. | $546.34 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $539.85 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $349.07 | 2021-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $311.35 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $277.94 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $263.83 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $236.70 | 2019-2022 | |
| Pfizer INC. | $228.70 | 2019-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $208.83 | 2024 | Arcalyst |
| Novo Nordisk INC | $207.29 | 2021-2025 | Ozempic, Wegovy |
| Cvrx, INC. | $196.50 | 2024-2025 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $186.26 | 2023-2025 | Optimizer, Optimizer |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Isaac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.